A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy

Jeon, Eun-Seok; Lim, Sang Wook; Kim, Seok-Yeon; Yang, Hyoung-Mo; Kim, Moo Hyun; Rhee, Moo-Yong; Han, Seung Hwan; Shin, Jinho; Kim, Kwang-il; Jeong, Jin-Ok; Sung, Ki Chul; Hong, Geu Ru; Kim, Hyung-Seop; Kwon, Kihwan; Kang, Tae-Soo; Lee, Hae-Young; Han, Su-Eun

doi:10.1186/s40885-022-00223-4

Clinical Hypertension

Article metrics
Last updated: Thu, 25 Apr 2024 22:16:43 Z

A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy

Access & Citations

3245

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 2056-5909

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com